Annual SGA
$35.82 M
+$4.84 M+15.63%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual SGA is $35.82 million, with the most recent change of +$4.84 million (+15.63%) on December 31, 2023.
- During the last 3 years, VYGR annual SGA has risen by +$831.00 thousand (+2.37%).
- VYGR annual SGA is now -3.82% below its all-time high of $37.25 million, reached on December 31, 2021.
Performance
VYGR SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$8.17 M
-$1.98 M-19.54%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly SGA is $8.17 million, with the most recent change of -$1.98 million (-19.54%) on September 30, 2024.
- Over the past year, VYGR quarterly SGA has dropped by -$2.07 million (-20.25%).
- VYGR quarterly SGA is now -30.56% below its all-time high of $11.76 million, reached on June 30, 2018.
Performance
VYGR Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.11 B
+$25.88 M+2.28%
September 30, 2024
Summary
- As of February 7, 2025, VYGR TTM SGA is -$1.11 billion, with the most recent change of +$25.88 million (+2.28%) on September 30, 2024.
- Over the past year, VYGR TTM SGA has dropped by -$1.14 billion (-3193.19%).
- VYGR TTM SGA is now -5219.21% below its all-time high of -$20.83 million.
Performance
VYGR TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
VYGR Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.6% | -20.3% | -3193.2% |
| 3 y3 years | +2.4% | -3.5% | -3676.6% |
| 5 y5 years | +6.0% | -3.5% | -3676.6% |
VYGR Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3.8% | +15.6% | -20.3% | +11.8% | at high | +27.1% |
| 5 y | 5-year | -3.8% | +15.6% | -21.7% | +11.8% | at high | +27.1% |
| alltime | all time | -3.8% | +555.0% | -30.6% | +549.8% | -5219.2% | +27.1% |
Voyager Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $8.17 M(-19.5%) | $37.17 M(-0.2%) |
| Jun 2024 | - | $10.15 M(+17.9%) | $37.26 M(+5.2%) |
| Mar 2024 | - | $8.61 M(-16.0%) | $35.40 M(-1.2%) |
| Dec 2023 | $35.82 M(+15.6%) | $10.24 M(+24.0%) | $35.82 M(+5.2%) |
| Sep 2023 | - | $8.26 M(-0.4%) | $34.04 M(+2.9%) |
| Jun 2023 | - | $8.29 M(-8.1%) | $33.09 M(+2.3%) |
| Mar 2023 | - | $9.03 M(+6.7%) | $32.35 M(+4.4%) |
| Dec 2022 | $30.98 M(-16.8%) | $8.46 M(+15.8%) | $30.98 M(+0.4%) |
| Sep 2022 | - | $7.31 M(-3.2%) | $30.87 M(-4.4%) |
| Jun 2022 | - | $7.55 M(-1.4%) | $32.28 M(-8.2%) |
| Mar 2022 | - | $7.66 M(-8.3%) | $35.16 M(-5.6%) |
| Dec 2021 | $37.25 M(+6.4%) | $8.35 M(-4.2%) | $37.25 M(+0.2%) |
| Sep 2021 | - | $8.71 M(-16.5%) | $37.16 M(+1.2%) |
| Jun 2021 | - | $10.44 M(+7.1%) | $36.73 M(+6.4%) |
| Mar 2021 | - | $9.74 M(+17.8%) | $34.53 M(-1.3%) |
| Dec 2020 | $34.99 M(-3.7%) | $8.27 M(-0.1%) | $34.99 M(-4.4%) |
| Sep 2020 | - | $8.28 M(+0.5%) | $36.61 M(-0.5%) |
| Jun 2020 | - | $8.24 M(-19.3%) | $36.80 M(-0.2%) |
| Mar 2020 | - | $10.21 M(+3.2%) | $36.88 M(+1.5%) |
| Dec 2019 | $36.34 M | $9.89 M(+16.9%) | $36.34 M(+4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $8.46 M(+1.7%) | $34.70 M(+5.6%) |
| Jun 2019 | - | $8.32 M(-13.8%) | $32.84 M(-9.5%) |
| Mar 2019 | - | $9.66 M(+17.0%) | $36.28 M(+7.3%) |
| Dec 2018 | $33.81 M(+71.3%) | $8.26 M(+24.9%) | $33.81 M(+9.3%) |
| Sep 2018 | - | $6.61 M(-43.8%) | $30.92 M(+5.7%) |
| Jun 2018 | - | $11.76 M(+63.8%) | $29.25 M(+32.9%) |
| Mar 2018 | - | $7.18 M(+33.8%) | $22.01 M(+11.5%) |
| Dec 2017 | $19.74 M(+48.7%) | $5.37 M(+8.6%) | $19.74 M(+10.6%) |
| Sep 2017 | - | $4.94 M(+9.4%) | $17.85 M(+9.7%) |
| Jun 2017 | - | $4.52 M(-8.1%) | $16.28 M(+11.4%) |
| Mar 2017 | - | $4.91 M(+41.2%) | $14.62 M(+10.2%) |
| Dec 2016 | $13.27 M(+33.9%) | $3.48 M(+3.3%) | $13.27 M(+2.5%) |
| Sep 2016 | - | $3.37 M(+18.1%) | $12.95 M(+7.4%) |
| Jun 2016 | - | $2.85 M(-19.9%) | $12.05 M(+4.0%) |
| Mar 2016 | - | $3.56 M(+12.9%) | $11.59 M(+17.0%) |
| Dec 2015 | $9.91 M(+81.2%) | $3.16 M(+27.6%) | $9.91 M(+19.6%) |
| Sep 2015 | - | $2.48 M(+3.3%) | $8.29 M(+17.2%) |
| Jun 2015 | - | $2.40 M(+27.4%) | $7.07 M(+51.3%) |
| Mar 2015 | - | $1.88 M(+22.5%) | $4.67 M(+67.3%) |
| Dec 2014 | $5.47 M | $1.54 M(+22.2%) | $2.79 M(+122.2%) |
| Sep 2014 | - | $1.26 M | $1.26 M |
FAQ
- What is Voyager Therapeutics annual SGA?
- What is the all time high annual SGA for Voyager Therapeutics?
- What is Voyager Therapeutics annual SGA year-on-year change?
- What is Voyager Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly SGA year-on-year change?
- What is Voyager Therapeutics TTM SGA?
- What is the all time high TTM SGA for Voyager Therapeutics?
- What is Voyager Therapeutics TTM SGA year-on-year change?
What is Voyager Therapeutics annual SGA?
The current annual SGA of VYGR is $35.82 M
What is the all time high annual SGA for Voyager Therapeutics?
Voyager Therapeutics all-time high annual SGA is $37.25 M
What is Voyager Therapeutics annual SGA year-on-year change?
Over the past year, VYGR annual SGA has changed by +$4.84 M (+15.63%)
What is Voyager Therapeutics quarterly SGA?
The current quarterly SGA of VYGR is $8.17 M
What is the all time high quarterly SGA for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly SGA is $11.76 M
What is Voyager Therapeutics quarterly SGA year-on-year change?
Over the past year, VYGR quarterly SGA has changed by -$2.07 M (-20.25%)
What is Voyager Therapeutics TTM SGA?
The current TTM SGA of VYGR is -$1.11 B
What is the all time high TTM SGA for Voyager Therapeutics?
Voyager Therapeutics all-time high TTM SGA is -$20.83 M
What is Voyager Therapeutics TTM SGA year-on-year change?
Over the past year, VYGR TTM SGA has changed by -$1.14 B (-3193.19%)